OA Task Force

Patients must be united if we are to advance in the same direction. For this reason, the Osteoarthritis Foundation International (OAFI) leads the implementation of the OA Patients Task Force, an alliance between the most important associations of patients with rheumatologic problems in order to work together globally with a focus on osteoarthritis.

About 150 million patients are represented in the group’s work meetings, formed by the Arthritis Foundation (USA),  Liga Española de Reumatología), the Pan-American League of Rheumatology Associations (PANLAR), in addition to the Osteoarthritis Foundation International (OAFI).

The OA Patients Task Force is currently working on the review of studies published worldwide on the quality of life of patients with osteoarthritis of the knee and it collaborates in the design, dissemination and analysis of a survey aimed at patients with osteoarthritis with the goal to understand their perceptions regarding the information about the disease, its prevention and treatment.

CHAIRMAN

Xavier Carné

Hospital Clínic de Barcelona / European Clinic Research Infrastructures Network (ECRIN), Spain

ENTIDADES

  • Ann Palmer
    Arthritis Foundation, USA
  • Guy Eakin
    Arthritis Foundation, USA
  • Josep Vergés
    Osteoarthritis Foundation International (OAFI), Spain
  • Carlo V. Caballero-Uribe
    Pan-American League of Rheumatology Associations (PANLAR), Colombia
  • Maritza Quintero
    Pan-American League of Rheumatology Associations (PANLAR), Venezuela
  • Yves Henrotin
    Osteoarthritis Foundation, Belgium

ASESORES EXPERTOS

  • Jordi Monfort
    Hospital del Mar, Spain
  • Marco Matucci
    Italian Rheumatology Association / Scieroderma Foundation, Italia
  • Ingrid Möller
    Institut Poal de Reumatologia, Spain
  • Francisco de Abajo
    Alcalá de Henares University – Medical School, Spain
  • Patrick du Souich
    Montréal University – Medical School, Canada
  • Virginia Kraus
    Duke University – Medical School, USA
  • Montserrat Romera-Baurés
    Sociedad Española de Reumatología (SER)

Help us improve the quality of life of osteoarthritis patients